Global levels of histone modifications predict prostate cancer recurrence. - Wikidata - wikimedia - TriplyDB

Global levels of histone modifications predict prostate cancer recurrence.

Global levels of histone modifications predict prostate cancer recurrence.

http://www.wikidata.org/entity/Q39899696

about

One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention Epigenetics meets radiation biology as a new approach in cancer treatment Epigenetic modulators as therapeutic targets in prostate cancer Histone demethylase lysine demethylase 5B in development and cancer The role of epigenetics in resistance to Cisplatin chemotherapy in lung cancer KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.Exploiting Epigenetic Alterations in Prostate Cancer.Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Histone H2A.Z deregulation in prostate cancer. Cause or effect?Epigenetics of prostate cancer and the prospect of identification of novel drug targets by RNAi screening of epigenetic enzymes.Epigenetic Signatures in Breast Cancer: Clinical Perspective Alterations of global histone H4K20 methylation during prostate carcinogenesis.Histone modifications and chromatin organization in prostate cancer Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells.SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells.Development of a nuclear morphometric signature for prostate cancer risk in negative biopsies.Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.Epigenetics in prostate cancer.Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update.Role of diet in prostate cancer: the epigenetic link.Epigenetic regulation of prostate cancer Proteomic profiling identifies specific histone species associated with leukemic and cancer cells γ-H2AX and other histone post-translational modifications in the clinic.Histone modifications and cancer: biomarkers of prognosis?microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2 Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.Endometriosis is characterized by a distinct pattern of histone 3 and histone 4 lysine modifications.Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy.Targeting oxidative stress in cancer.Epigenetic modifications as therapeutic targets.The path to epigenetic treatment of memory disorders.Hypomethylation of repeated DNA sequences in cancer.Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer.The oncogenic potential of Jumonji D2 (JMJD2/KDM4) histone demethylase overexpression.Prostate cancer epigenetic biomarkers: next-generation technologies.

P2860

Q26740548-5FA547EC-7B9F-4A82-8D58-E766EE168076 Q26994739-00E1535D-4F67-4DBC-8F97-B94BFC8094B1 Q27014984-57A7B432-6418-48E6-8968-DC264AB54753 Q28071912-BB4B69EE-4E6E-45EE-BB44-5D6DE45309BC Q28076257-47B76198-0D56-451F-A5B8-BA077D572310 Q28387891-74EBE39C-8E44-4564-81A4-9F7787EB1CB5 Q33580494-4074EE83-E859-46F8-A948-DA87BC59D3CB Q33755160-D5ED67DB-853E-4217-9076-00A559CE5B16 Q33838513-23F5E4AF-6471-4D42-B994-E48B51988CE7 Q33962848-217BAFB7-320D-40CF-8731-95CC09292BEB Q34084746-8CB02C07-8A97-4026-8920-BA8713DCAC3D Q34095995-0A2B1AAD-B64C-427D-BD9C-8D68639A82A1 Q34194181-2DDADC6E-544A-4206-AEF9-A502E9F97C9F Q34559303-A5F36690-3B8B-4F9A-B0BB-730F753330E7 Q34581453-5929C8CC-00AC-4CFA-B8AE-90AC0FC605BC Q34766981-A8667982-9B0F-4230-A120-91F20A06F84E Q34902668-21A8D403-60AF-4B16-9848-8982C17D04C8 Q35163061-4D9A437E-25D1-47F0-81C8-AB4DC7652CE6 Q35176138-21CA7D6E-6268-4B12-B99D-4DC0AF42ECA7 Q35608952-BC7C126D-C481-4939-860B-A297F93E240D Q35726371-0BAD26A2-D3D8-4BC2-8C24-E28CE8ECF35D Q35768176-64CF1DF3-A0CB-4745-BEC3-530A7E7539C3 Q36001910-4D8E544B-A3D3-47FE-BBA6-0203889D4134 Q36001960-68B59D49-5CF6-4181-A2FB-ECA29CC60A7E Q36019818-9DA8A951-536D-4A10-A402-E684D84F1851 Q36206499-A91A40D3-5B5B-476C-8416-B438FA28EFF4 Q36230699-CF6BCCAE-1E5C-4254-8EEF-AA5985CFB521 Q36515134-BFC1C147-D76F-4A24-95D0-D266FBAAE375 Q37349488-A7CB0124-649D-420A-B6D8-8B5ED959AE26 Q37606205-11B6A13A-FAF1-4458-B8FD-0F4C4460B997 Q37629542-98AB714A-4F61-476B-A3E5-D60559785988 Q37730440-48E8E4F5-ED53-45B8-8D2E-7A1AF44E6523 Q37799839-D2FBD474-A533-4BCF-A812-7FF3861649DC Q37800011-48DAFFFC-4E44-48A7-B963-23C744B24F4C Q37841833-BE98780A-BAE7-467F-8A57-7D07A2431210 Q37961724-0F404098-E8D2-49EA-8B85-42676AFCE9BE Q38002825-ED720EC5-1619-4C59-B992-21CFBE077E6F Q38160734-E2EC7D68-6C0A-4188-A994-894C25AF6816 Q38161942-5820428A-E4D3-44DA-AC01-45CD281D2994 Q38212471-D984D1DE-AC77-4709-B4AC-3C2E3FEF7C2C

P2860

Global levels of histone modifications predict prostate cancer recurrence.

http://www.wikidata.org/entity/Q39899696

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Global levels of histone modifications predict prostate cancer recurrence.

@en

Global levels of histone modifications predict prostate cancer recurrence.

@nl

type

label

Global levels of histone modifications predict prostate cancer recurrence.

@en

Global levels of histone modifications predict prostate cancer recurrence.

@nl

prefLabel

Global levels of histone modifications predict prostate cancer recurrence.

@en

Global levels of histone modifications predict prostate cancer recurrence.

@nl

P1433

Q39899696-69ACCD0D-0ADF-4C85-98B7-C433F7481298

P1476

Q39899696-87BE0E96-1E55-45E4-A9C5-F2B9CFECEC2F

P2093

Q39899696-060E8C41-451F-4F52-9C22-526CA00F17A2

Q39899696-081781BE-A042-40A0-ADD9-CB18AD83A5F8

Q39899696-5CA6BCF8-6DB6-4C19-A73C-0F2D5C4C6161

Q39899696-704ACFD2-BD65-414B-BF1C-26F8547FBCD2

Q39899696-9A600A24-D001-4033-A27C-CBDE6072FB7F

Q39899696-9E240BFB-4049-4EBD-8F21-16E1D5840A2D

Q39899696-A8DF8C95-9CE7-4023-85A7-562766B181C1

Q39899696-ACC1B8E7-25DD-410F-811F-F18317B0A08F

Q39899696-C06BC79F-0E17-43CF-BBFE-C41F568F3F85

Q39899696-DEFE6CDD-4523-4AD7-A755-698122DB9928

P304

Q39899696-D1A6449F-8E02-4DF1-9EA4-1E47B3AEA20D

P31

Q39899696-5482545F-A1AD-4AFD-B697-807B9C02B9EE

P356

Q39899696-26B5EACD-A5F8-40B2-9B57-632A2EBB2E4D

P433

Q39899696-6F7599B5-2AA3-43FE-B1D4-29E3DD017BE7

P478

Q39899696-0BF6AD1E-0550-4232-AADC-62208F9CF3FE

P50

Q39899696-15482F10-783B-4A9F-97A3-42BE454014DC

P577

Q39899696-A7DF7562-84EE-4116-AF2F-5CCC612668B4

P698

Q39899696-543CE1DD-F9AE-40EE-8A85-C7F1F29DFDFF

P356

P1433

P1476

Global levels of histone modifications predict prostate cancer recurrence

@en

P2093

Alexander von Ruecker

http://www.w3.org/2001/XMLSchema#string

Bernhard Walter

http://www.w3.org/2001/XMLSchema#string

Ferdinand Hofstädter

http://www.w3.org/2001/XMLSchema#string

Ines Gütgemann

http://www.w3.org/2001/XMLSchema#string

Johannes von der Gathen

http://www.w3.org/2001/XMLSchema#string

Jörg Ellinger

http://www.w3.org/2001/XMLSchema#string

Patrick J Bastian

http://www.w3.org/2001/XMLSchema#string

Philip Kahl

http://www.w3.org/2001/XMLSchema#string

Reinhard Büttner

http://www.w3.org/2001/XMLSchema#string

Sebastian Rogenhofer

http://www.w3.org/2001/XMLSchema#string

P304

61-69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21038

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Lukas C Heukamp

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19739128

http://www.w3.org/2001/XMLSchema#string